Estados Unidos · Revistas de economía · Quartz

Merck topped estimates and raised its profit forecast as cancer drug injection took off

Publicado por Quartz · Estados Unidos hace 2 h

Adjusted profit forecast moves to $2.77 to $2.82 a share from $2.66 to $2.76 as Keytruda Qlex sales reach $830 million

Leer el artículo completo en Quartz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (qz.com)

También te puede interesar

Boston Beer Says Hard Sports Drinks Are the Next Big Thing. Making Them Safely Is a Major Challenge

Markets Insider (Business Insider)

Alphabet stock on track for worst day ever after rare earnings miss

‘The inflation outlook has become more concerning’: Incomes declined 0.3% and consumer prices jumped 3.6% in September as midterms loom

Anthropic’s IPO is selling investors a story. The numbers tell another one

Your Adjustable-Rate Mortgage Is About to Reset. Here Are 5 Moves to Make Now

You Can’t Declare a Culture Into Existence. You Have to Build One